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Abstract. 
 
Merlin, the product of the 
 
Neurofibromatosis 
type 2 
 
(
 
NF2
 
) tumor-suppressor gene, is a member of the 
protein 4.1 superfamily that is most closely related to 
ezrin, radixin, and moesin (ERM). NF2 is a dominantly 
inherited disease characterized by the formation of bi-
lateral acoustic schwannomas and other benign tumors 
associated with the central nervous system. To under-
stand its cellular functions, we are studying a Merlin ho-
mologue in 
 
Drosophila
 
. As is the case for NF2 tumors, 
 
Drosophila
 
 cells lacking 
 
Merlin
 
 function overprolifer-
ate relative to their neighbors. Using in vitro mutagene-
sis, we define functional domains within Merlin re-
quired for proper subcellular localization and for 
genetic rescue of lethal 
 
Merlin
 
 alleles. Remarkably, the 
results of these experiments demonstrate that all essen-
tial genetic functions reside in the plasma membrane–
 
associated NH
 
2
 
-terminal 350 amino acids of Merlin. 
Removal of a seven–amino acid conserved sequence 
within this domain results in a dominant-negative form 
of Merlin that is stably associated with the plasma 
membrane and causes overproliferation when ex-
pressed ectopically in the wing. In addition, we provide 
evidence that the COOH-terminal region of Merlin has 
a negative regulatory role, as has been shown for ERM 
proteins. These results provide insights into the func-
tions and functional organization of a novel tumor sup-
pressor gene.
 
R
 
ecent
 
 studies have identified a rapidly growing
number of tumor suppressor genes whose normal
function in cells directly or indirectly regulates cel-
lular proliferation. Not surprisingly, many of these genes,
such as 
 
Rb
 
 and 
 
p53
 
, have been shown to encode proteins
that regulate aspects of the cell cycle (for review see
Brown, 1997). However, other tumor suppressor genes ap-
pear to function in processes less clearly related to control
of the cell cycle. One of the most intriguing genes of this
latter class is the 
 
Neurofibromatosis type 2
 
 (
 
NF2
 
)
 
1
 
 gene,
which encodes a member of the protein 4.1 superfamily,
Merlin (Rouleau et al., 1993; Trofatter et al., 1993). Mem-
bers of the protein 4.1 superfamily, a large group of mem-
brane-associated cytoplasmic proteins, include protein 4.1;
talin; the ezrin, radixin, moesin (ERM) proteins; Merlin;
 
Drosophila
 
 Expanded; several protein phosphatases; and
at least two nonmuscle myosins (for review see McCartney
and Fehon, 1997). The defining feature of this superfamily
is a conserved region of 200–300 amino acids usually lo-
cated in the NH
 
2
 
 terminus of the protein. This region is
particularly well conserved between Merlin and the ERM
proteins. The ERM proteins appear to function as molecu-
lar linkers by binding to transmembrane proteins through
the NH
 
2
 
-terminal domain and linking them to the cortical
actin cytoskeleton through a COOH-terminal actin-bind-
ing domain. Consistent with this role, ERM proteins local-
ize to actin-rich structures such as the adherens junction
and microvilli (Franck et al., 1993; Takeuchi et al., 1994).
Although the structural similarities between Merlin and
the ERM proteins suggest that they may have similar func-
tions, the exact nature of Merlin’s cellular functions has
not been defined. Recent studies in cultured cells indicate
that expressed Merlin protein accumulates in some actin-
rich membrane domains, such as membrane ruffles at the
leading edge of migrating cells (Gonzalez-Agosti et al.,
1996; Sainio et al., 1997), consistent with the localization of
ERM proteins. However, several lines of evidence indi-
cate that Merlin has functions that are clearly distinct from
those of ERM proteins. First, although the NH
 
2
 
-terminal
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1. 
 
Abbreviations used in this paper
 
: AEL, after egg laying; AHS, after heat
shock; BB, Blue Box region; BBA, Merlin with the seven Blue Box resi-
dues changed to alanine; CNS, central nervous system; CNTR, conserved
NH
 
2
 
-terminal region; 
 
D
 
BB, Merlin with Blue Box region removed;
 
 
 
ERM,
ezrin-radixin-moesin; FLP, yeast 2 micron Flipase enzyme; FRT, Flipase
Recognition Target site; GFP, green fluorescent protein; 
 
Mer
 
, 
 
Merlin
 
;
NF2, Neurofibromatosis type 2; S2 cells, Schneider line 2 cells; UAS, up-
stream activation sequences of yeast Gal4 transcription factor.
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domains of Merlin and the ERM proteins are similar (the
protein 4.1 superfamily domain), Merlin lacks the well-
defined COOH-terminal actin-binding domain found in
ERM proteins (Turunen et al., 1994; Gary and Bretscher,
1995). In addition, while the ERM proteins are function-
ally redundant (Takeuchi et al., 1994), there is no evidence
for redundancy between the ERM proteins and Merlin.
The 
 
NF2/Merlin
 
 gene can be mutated to lethality in both
 
Drosophila
 
 and mouse (Fehon et al., 1997; McClatchey et
al., 1997). Finally, in vivo studies of subcellular localization
of Merlin and Moesin reveal that they can be distinct,
again supporting the idea that these proteins have differ-
ent functions (McCartney and Fehon, 1996).
To define the cellular functions of Merlin and the ERM
proteins, we have isolated and characterized two 
 
Dro-
sophila
 
 genes, 
 
Moesin
 
, the sole ERM gene in 
 
Drosophila
 
,
and 
 
Merlin
 
, a well conserved 
 
NF2
 
 homologue (McCartney
and Fehon, 1996). In the present study, we show that 
 
Mer-
lin
 
 is essential for viability in 
 
Drosophila
 
 and is required
for the proper regulation of cell proliferation. Further-
more, our analysis indicates that essential Merlin functions
occur at the cytoplasmic face of the cell membrane and
that all of these functions can be mediated by the con-
served NH
 
2
 
-terminal region.
 
Materials and Methods
 
Drosophila Cultures and Stocks Used
 
All 
 
Drosophila
 
 cultures were maintained on standard corn meal, yeast,
molasses, and agar medium. 
 
w
 
1118
 
 stocks were used for the transformation
of 
 
UASMerlin
 
 transgenes. The Merlin alleles used in this study are de-
scribed in Fehon et al. (1997).
 
Somatic Mosaic Analysis and Histology of Adult Eyes
 
Fly stocks capable of producing clones were generated by crossing 
 
w
 
1118
 
sn
 
3
 
 
 
Mer* P{neoFRT}19A/FM6
 
 with 
 
y w P{w[
 
1
 
mC]
 
 
 
5
 
 
 
PiM}5A
P{w[
 
1
 
mC]
 
 
 
5
 
 
 
PiM}10D P{neoFRT}19A/Y;P{hs-FLP}, Sb/TM6B.
 
 Off-
spring from this cross were heat shocked at either 36 or 72 h after egg lay-
ing (AEL) using one of two different heat shock regimens: 30 min at 38
 
8
 
C,
60 min at 25
 
8
 
C, and 30 min at 38
 
8
 
C or 60 min at 38
 
8
 
C, 60 min at 25
 
8
 
C, and
60 min at 38
 
8
 
C. In the adult, mutant clones were marked with 
 
w
 
1118
 
 
 
in the
eye and 
 
sn
 
3
 
 in the thorax; wild-type sister clones were marked in the eye
with four copies of the 
 
mini-white
 
 transgene and in the thorax with the 
 
yel-
low
 
 mutation. To analyze clone size in the eye, flies were placed in vented
Eppendorf tubes (Madison, WI) and flash frozen in liquid nitrogen. The
treated flies were dried with dry carbon dioxide, and the heads were then
dissected with a razor blade and mounted on a glass slide on double stick
tape. Eyes were examined and ommatidia counted with the compound mi-
croscope using transmitted light and the 10
 
3
 
 objective. Fixation and sec-
tioning of adult eyes was performed as previously described (Tomlinson
and Ready, 1987), with the exception that the tissue was postfixed in 2%
OsO
 
4
 
 and embedded in Araldite resin.
 
Wing Measurements
 
Wing cuticles were prepared by first incubating the entire fly in 70% etha-
nol and then submerging it in a drop of water on a siliconized slide, where
the wings were dissected away and mounted in 
 
z
 
30 
 
m
 
l Aquamount (BDH
Laboratory Supplies, Poole, England) on a glass slide. Only wings that
had been well flattened during the mounting process were used for further
analysis. Camera lucida drawings were made of the wing perimeter, wing
veins, and any ectopic veination. These drawings were then scanned at 75
dots per inch using a flatbed scanner and analyzed using the “measure”
tool in NIH Image. The area of the entire wing or the individual areas be-
tween the wing veins (the intervein regions) were determined and ex-
pressed in square millimeters.
 
Sequencing of Mutant Merlin Alleles
 
Genomic DNA was obtained from single first instar larvae hemizygous for
each 
 
Merlin
 
 allele (marked with 
 
yellow
 
). 
 
Merlin
 
 genomic DNA was ampli-
fied using intron-specific primers. The resulting PCR products were se-
quenced using the AmpliCycle sequencing kit (Perkin-Elmer Corp.,
Branchburg, NJ).
 
Construction of Truncated Merlin Proteins
 
A Bluescript shuttle vector was generated with an NH
 
2
 
-terminal myc
epitope tag by annealing two primers, consmyc S (sense) 5
 
9 
 
AAT TCA
CCA TGG AGC AAA AGC TCA TTT CTG AAG AGG ACT TGA
GGC CTA A and consmyc A (antisense) 5
 
9 
 
GAT CTT AGG CTT CAA
GTC CTC TTC AGA AAT GAG CTT TTG CTC CAT GGT G, which
produce a duplex with over-hanging EcoRI and BglII ends. This fragment
was subsequently cloned into an EcoRI/BamHI-cut Bluescript SK
 
2
 
 plas-
mid. (All restriction enzymes were obtained from New England Biolabs,
Beverly, MA.) Digestion of the modified vector with StuI allowed PCR-
generated 
 
Merlin
 
 transgenes to be cloned in-frame immediately down-
stream of the myc epitope.
All 
 
Merlin
 
 constructs were generated by PCR amplification from a full-
length Merlin cDNA clone (McCartney and Fehon, 1996). The sequence
of all PCR-amplified regions was confirmed by sequencing using standard
methods. To make upstream activation sequences of the yeast Gal4 tran-
scription factor (UAS) expression constructs, a XhoI/XbaI fragment from
the BSSK-myc shuttle vector was then cloned into an XhoI/XbaI-pre-
pared pUASt transformation vector (Brand and Perrimon, 1993). Trans-
formation of these constructs was performed as described (Rebay et al.,
1993). 4–10 independent lines were established for each construct.
To construct BSSK-
 
myc Mer
 
D
 
BB
 
, the 5
 
9 
 
half of 
 
Merlin
 
 was amplified us-
ing the M13 Universal Primer of the BSSK
 
2
 
 vector, and an antisense
 
Merlin
 
 primer within which a PvuII site was engineered (underlined in
primer sequence): 5
 
9 
 
GCG TCA TCT GCA GCT GAT GCG. This prod-
uct was then digested with EcoRI and PvuII. The 3
 
9
 
 
 
Mer
 
D
 
BB
 
 region was
similarly generated using M13 reverse and an internal Merlin sense primer
whose 5
 
9
 
 sequence began at codon 177: 5
 
9 
 
TGG GAG GAA CGG ATC
AAG ACA TGG; this product was digested with PstI and ligated together
with the 5
 
9
 
 piece into an EcoRI/PstI cut BSSK-
 
mycMer
 
1
 
. Positive clones
were sequenced to verify the presence of the deletion. The BSSK-
 
myc-
Mer
 
BBA
 
 vector was constructed in a similar manner using sense (5
 
9
 
 TAC
CAG ATG ACC GCG GCA GCG TGG GAG GAA CGG) and anti-
sense (5
 
9
 
 CTC CCA CAT TTC CGC GGC TGC TGC GGC CTG ATC
GGT CAC TCC) primers that changed amino acids 171–177 to alanines
and contained a SacII site for cloning (underlined in primer sequence). To
make BSSK-
 
mycMer
 
3
 
, a genomic PCR fragment containing the 
 
Mer
 
3
 
 mu-
tation was digested with NheI and NspI. A BSSK-
 
mycMer
 
1
 
 vector was
prepared by a complete NheI digest and a partial NspI digest. (The site is
unique in 
 
Merlin
 
, but another site is in the BSSK
 
2
 
 vector.) A ligation was
performed using the prepared PCR product and the NheI/NspI-prepared
BSSK
 
2
 
 myc tag vector. Positive clones were sequenced to detect the pres-
ence of the point mutation.
To make Merlin green fluorescent protein (GFP) fusion proteins,
UAS
 
mycMer
 
1
 
,
 
 UAS
 
mycMer
 
D
 
BB
 
, UAS
 
mycMer
 
BBA
 
, and UAS
 
mycMer
 
3
 
were digested with BglII and SacI. The SacI site is unique in 
 
Merlin
 
 and is
located in the last codon of the 
 
Merlin
 
 open reading frame. A GFP frag-
ment was excised from pGEM7GFPRS (a gift of Kevin Edwards and Dan
Kiehart, Duke University) using SacI and XbaI. The SacI site lies eight
codons 5
 
9
 
 to the start ATG of the GFP open reading frame and is in-frame
to the 
 
Merlin
 
 open reading frame. A pCaSpeR-hs vector was prepared us-
ing BglII and XbaI. A three-piece ligation was performed using gel-puri-
fied fragments of 
 
Merlin
 
, GFP, and the prepared pCaSpeR-hs vector.
 
Transfection of Schneider 2 Cells and In Vivo 
Competition Experiments
 
For expression of the truncated Merlin fragments in Schneider line 2 (S2)
cultured cells, two sets of expression constructs were used: pCaSpeR-hs, a
heat shock inducible vector, and pRmHa-3, an inducible metallothionein
promoter vector. For the heat shock vectors, a BglII/XbaI fragment from
the UAS 
 
Merlin
 
 truncation constructs was cloned into a BglII/XbaI-pre-
pared pCaSpeR-hs vector. To generate pRmHa-3, a BglII/BamHI frag-
ment from pCaSpeR-hs 
 
Merlin
 
 constructs was cloned into BamHI-pre-
pared pRmHa-3. The maintenance, induction, and immunofluorescent
analysis of S2 cells was performed as previously described (Fehon et al., 
LaJeunesse et al. 
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1990). In the time course experiments, transfected S2 cell cultures were in-
duced with a 20 min/38
 
8
 
C heat shock; samples were then collected at time
points 1, 3, and 6 h after heat shock (AHS) induction. The samples were
fixed and stained with a mouse anti-myc antibody 9c10.
For the
 
 
 
in vivo competition experiment, we cotransfected S2 cells with
two different plasmids: a pRmHa-3 myc-tagged 
 
Merlin
 
 construct (either
wild-type 
 
Merlin
 
, 
 
Merlin
 
1–600
 
, or 
 
Merlin
 
D
 
BB
 
) and a pCaSpeR-hs non–myc-
tagged 
 
Merlin
 
 GFP fusion protein construct. The transfected cells were
treated with a CuSO
 
4
 
 solution (final concentration 0.6 mM) to induce the
metallothionein promoter, incubated for 3 h, and heat shocked for 20 min/
38
 
8
 
C to induce expression of the heat shock construct. Samples were col-
lected 5 h AHS, fixed, and stained with a mouse anti-myc antibody.
 
Determination of In Vivo Activity
 
To determine the rescue activity of our 
 
UASMer
 
 transgenes,
 
 y
 
1 w1118 Mer/
FM7; T80Gal4/T80Gal4 females were crossed to UASmycMer transgenic
males. Four equal classes of flies would be expected from this cross, in-
cluding males hemizygous for a Merlin mutation that lack endogenous
Merlin function. To determine the percentage of rescue, the number of F1
progeny excluding the rescued hemizygous males was divided by three to
yield the predicted number of mutant offspring. The number of observed
mutant progeny (marked by yellow) was then divided by this number to
yield the percentage of rescue. The numbers were then normalized to the
rescue provided by Merlin1–600, which provided the greatest rescue.
Results
Characterization of Mutations within the Drosophila 
Merlin Gene
The Drosophila Merlin gene is located on the X chromo-
some at cytological position 18D-E. Four mutations within
Merlin have been previously identified (Fehon et al.,
1997). Although none of these alleles causes embryonic
lethality, three of these mutations cause larval and pupal
lethality without strong distinguishing phenotypes. The
three lethal Merlin alleles encode putative truncated pro-
teins as a result of nonsense mutations: Merlin1 (Mer1),
Gln324 to stop; Mer2, Gln318 to stop; Mer4, Gln170 to
stop. A single viable allele, Mer3, was recovered from
these screens and is due to a missense mutation of Met177
to Ile. Flies homozygous for Mer3 survive as viable, sterile
adults and display a broadened wing phenotype along with
low and variably penetrant expression of weakly rough-
ened eyes and the development of abnormal head cuticle
structures (data not shown). Although no genetic defi-
ciency exists to test for residual function of these alleles,
we conclude that Mer4 is likely a null mutation based on
the severity of the truncation predicted for this allele.
To characterize the cellular phenotypes of Merlin, we
performed a somatic mosaic analysis using the yeast 2
micron Flipase enzyme/Flipase Recognition Target site
(FLP/FRT) system (Golic and Lindquist, 1989; Xu and
Rubin, 1993). The parental chromosome of all four Mer al-
leles carries an FRT site at cytological position 19A. Al-
though previous experiments mapped Merlin distal to this
FRT at 18D-E, we confirmed that Mer2 clones were gen-
erated after heat shock FLP induction by staining mosaic
tissue with the Merlin antibody (data not shown). In the
adult eye, mutant clones were identified by the lack of pig-
ment due to the presence of the white mutation; wild-type
sister clones were marked by a dark orange eye color, and
heterozygous ommatidia were pale orange. The overall
morphology of the eye within the mutant clone appeared
normal (Fig. 1 B), although mutant clones occasionally
displayed a very weak roughened phenotype (data not
shown). Histological sections of these clones revealed es-
sentially normal differentiation of ommatidia with only a
few disruptions in the organization of ommatidia when
compared with the neighboring wild-type cells (Fig. 1 C).
Comparison of genetically marked, wild-type (control),
and Mer2 mutant clones in the eye suggested that the mu-
tant clones were consistently larger than their wild-type
Figure 1. Mer mutant clones in the eye overproliferate relative to
control clones. (A) Control clone w1118 sn3 19AFRT and (B) mu-
tant clone w1118 sn3 Mer319AFRT induced at 72 h AEL. In all
cases, the mutant or control clone is marked with w1118 (white),
and the wild-type sister clone is marked with four copies of mini-w1
(red). The heterozygous background is marked with two copies of
mini-w1 (orange). Comparison of the mutant clone to either its
sister clone or to the control clone reveals that the Merlin mutant
clone is consistently larger, containing more ommatidia. Histo-
logical sections of a w1118 sn3 Mer4 clone induced at 36 h AEL (C)
reveal essentially no abnormal phenotypes in the ommatidial
morphology of the homozygous mutant tissue. This tissue can be
distinguished from the neighboring heterozygous or homozygous
wild-type tissue by the lack of pigment granules (yellowish spots)
due to the w1118 marker. (D) Summary of the proliferation analy-
sis of Merlin mutant clones. When the t test was applied to these
data, the difference in ratio between the control and all four Mer-
lin mutants was found to be significant (P , 0.001).The Journal of Cell Biology, Volume 141, 1998 1592
sisters. To address this possibility, we compared the num-
ber of ommatidia within each mutant clone to the number
of ommatidia in its sister clone and generated a ratio of
mutant clone size to wild-type sister clone size. When a
control clone was generated, the area of the white2-
marked clone was equal to that of its white1 sister (Fig. 1
A and D). In contrast, Merlin mutant clones ranged from
2.1 to 2.7 times the size of their wild-type sisters, depend-
ing on the allele of Merlin examined (Fig. 1, B and D). This
observation suggests that the Merlin mutant cells either pro-
liferate more rapidly than their wild-type neighbors or that
they continue proliferating later in development. Another
possible explanation is that the mutant cells have a defect in
cell death leading to apparent overproliferation. Acridine
orange staining of Merlin mutant imaginal discs did not indi-
cate any changes in the level of cell death, however (data not
shown). Because loss of Merlin function in clones results in
overproliferation without any gross morphological defects,
we conclude that Merlin functions in a process that specifi-
cally affects the regulation of proliferation.
In Vitro Mutagenesis
To further investigate its cellular roles, we generated NH2-
and COOH-terminal truncations of the Merlin protein
(Fig. 2 A). These mutations were used to perform two sets
of experiments: First, we examined the subcellular local-
ization of these mutant Merlin proteins when expressed in
cultured cells and in tissue, and second, we examined their
in vivo genetic functions. The fragments of Merlin gener-
ated for the structure/function analysis were selected
based on comparisons with human Merlin and with the
ERM proteins (McCartney and Fehon, 1996), with the as-
sumption that regions that are highly conserved are likely
to have functional significance. The molecular organiza-
tion of Merlin is similar to that of ERM family members
and consists of an NH2-terminal protein 4.1 domain, a pu-
tative coiled-coil domain, and a COOH-terminal region
(Fig. 2 A). Because of the apparent modular nature of
Merlin, we generated several Merlin truncations that con-
tained portions of the NH2- or COOH-terminal halves of
the protein and a truncation containing only the central
coiled-coiled region. The size and stability of each Merlin
truncation was verified by immunoblot (Fig. 2 B). In addi-
tion, we examined the conserved NH2-terminal region
(CNTR) in greater detail. The CNTR is nearly 60% identi-
cal between Merlin and the ERM proteins; however, a
closer examination of this region revealed seven amino ac-
ids (170YQMTPEM177) that are identical in human and
Drosophila Merlin but are divergent from the ERM pro-
teins (McCartney and Fehon, 1996). The possible func-
tional significance of this region is further supported by
the presence of the Mer3 missense mutation at amino acid
177. We have named this region “the Blue Box” (BB). To
investigate the functional significance of the BB, we engi-
neered two Merlin proteins, one lacking the BB region
(mycMerDBB) and one in which the BB is replaced by a
polyalanine stretch (mycMerBBA). Furthermore, to define
the nature and the activity of the original Mer3 allele, we
generated a myc-tagged version of this allele (mycMer3).
The Subcellular Localization of Merlin In
Vitro Mutants
We examined the subcellular localization of these Merlin
fragments in Drosophila S2 cultured cells and in the imagi-
Figure 2. (A) Schematic represen-
tation of myc-tagged forms of Mer-
lin and their ability to rescue Mer4
lethality. The name of each Mer al-
lele corresponds to the amino acid
residues present in the construct.
Relative rescue was defined as the
percentage of Mer4 hemizygous
males that survive compared with
expected (calculated from sibling
classes, see Materials and Meth-
ods). The data is represented as an
average of at least three separate
experiments using two to five inde-
pendent insertion lines (number
shown in parenthesis). (B) Immu-
noblot of whole S2 cell extract
transfected with myc-tagged Mer-
lin heat shock transgenes, probed
with anti-myc antibody 9c10: lane 1,
mycMer1; lane 2, mycMer1–600; lane 3, mycMer1–375; lane 4, mycMer 1–350; lane 5, mycMer1–330; lane 6, mycMer351–600; lane 7, mycMer 351–635.
Bullets denote each Merlin fragment.LaJeunesse et al. Functional Analysis of Drosophila NF2/Merlin Homologue 1593
nal disc epithelium to identify regions within Merlin that
are required for proper subcellular localization. Experi-
ments in cultured cells allowed us to examine both the
temporal patterning and the subcellular localization of
Merlin. As previously reported (McCartney and Fehon,
1996), wild-type Merlin is initially targeted to the mem-
brane, and within 3 h, much of the protein localizes to
punctate cytoplasmic structures (Fig. 3, A–C). A similar
pattern (membrane-associated and cytoplasmic staining)
was also observed in endogenously expressed Merlin in S2
cells (data not shown) and within the imaginal disc epithe-
lium (McCartney and Fehon, 1996; Fig. 3 D). Removal of
the conserved COOH-terminal 35 amino acids resulted in
a protein, mycMer1–600, that was localized almost exclu-
sively at the plasma membrane and did not appear to in-
ternalize (Fig. 3, E–G). This observation suggests that the
COOH-terminal 35 amino acid residues play a role in
Merlin internalization. In the imaginal epithelia of trans-
genic larvae, this truncated Merlin protein was localized to
the plasma membrane (similar to the localization of wild-
type Merlin) but did not display the punctate cytoplasmic
localization characteristic of the wild-type protein (Fig. 3
H). More severe COOH-terminal truncations of Merlin,
mycMer1–350 (Fig. 3, I–L) and mycMer1–375 (data not
shown) appeared to associate less strongly with the plasma
membrane, suggesting that within the COOH terminus
there are sites required for proper localization. Consistent
with this notion, mycMer351–635 (Fig. 3, M–P) and
mycMer351–600 (data not shown), which retain most of the
COOH-terminal half of Merlin but none of the CNTR,
were highly membrane associated in both cultured cells
and imaginal tissue. Of the other Merlin constructs,
mycMer1–330 localized diffusely throughout the cytoplasm
with no distinct subcellular location, while mycMer1–169
and mycMer601–635 had little or no expression (data not
shown), owing possibly to their inherent instability. We
conclude from these results that components of both the
NH2- and COOH-terminal halves of Merlin are required
for its correct targeting to the plasma membrane.
To assess the role of the Blue Box (BB) region in Mer-
lin’s subcellular localization, we examined the subcellular
distribution of wild-type and mutant proteins fused to
green fluorescent protein (GFP). Wild-type Merlin-GFP
(GFPMer1) retains full wild-type rescue function; thus,
Figure 3. Subcellular local-
ization of myc-tagged Merlin
truncations in Drosophila
S2 cells and wing imaginal
disc epithelia: mycMer1
(A–D), mycMer1–600 ( E–H),
mycMer1–350 ( I–L), and
mycMer351–635 ( M–O). All
samples were stained with
mouse anti-myc antibody
(9c10) and a CY3-conjugated
secondary antibody. In the
cultured cell experiments,
samples were collected from
three time points AHS in-
duction: 1 h AHS (A, E, I,
and M); 3 h AHS (B, F, J,
and N); and 6 h AHS (C, G,
K, and O). Localization of
the Merlin truncations was
also examined in larval wing
imaginal discs (D, H, L, and
P). All images of the imagi-
nal epithelium are tangential
optical sections of the apical-
most focal plane. In S2 cells,
mycMer1 ( A–C) has a tem-
poral and spatial pattern sim-
ilar to that described previ-
ously for expressed wild type
protein (McCartney and Fe-
hon, 1996). Initially, Merlin is
targeted to the plasma mem-
brane (A); after 3 h, much of
the protein is found in the cytoplasm in punctate cytoplasmic structures (B and C). The localization of mycMer1 in the imaginal epithe-
lium showed characteristic localization to the apical plasma membrane and in the cytoplasm (D). The COOH-terminal truncation,
mycMer1–600, localized to the plasma membrane but had no punctate cytoplasmic staining (E–H). Initially in S2 cells, much of the 350–
amino acid NH2-terminal Merlin fragment was distributed throughout the cytosol (I and J); however, 6 h AHS, much of the protein is
found at the plasma membrane (K). In an imaginal epithelia, this protein is found in the apical plasma membrane and throughout the
cytoplasm (L). Deletion of the NH2-terminal domain in mycMer351–635 results in a protein that localizes to the plasma membrane in both
cultured cells and imaginal epithelium (M–P). Bar, 5 mm.The Journal of Cell Biology, Volume 141, 1998 1594
the GFP moiety does not interfere with Merlin function
(data not shown). In S2 cells, GFPMer3 remained associ-
ated with the membrane 3–5 h after heat shock (Fig. 4,
E–G), unlike GFPMer1, which had all internalized by this
time (Fig. 4, A–C). Removal or replacement of the entire
BB resulted in proteins that were properly targeted to the
plasma membrane but were not internalized (Fig. 4, I–K).
Similarly, in imaginal epithelia, MerDBB was exclusively
plasma membrane associated (Fig. 4 L).
Characterization of In Vivo Function
To assay the in vivo function of the mutant Merlin pro-
teins, we used the Gal4/UAS system (Brand and Perri-
mon, 1993) to express Merlin truncations in mutant and
wild-type genetic backgrounds. In these studies, we ad-
dressed two questions: First, what is the minimal protein
region required for Merlin function, and second, do any
mutant Merlin proteins produce antimorphic (dominant-
negative) phenotypes when expressed in vivo? In the
genetic rescue experiments, UASMerlin constructs were
driven under a ubiquitously expressing Gal4 enhancer trap
(T80Gal4) in a Mer4 mutant background and tested for
their ability to rescue Mer4 lethality. Complementation of
the other lethal Merlin alleles (Mer1 and Mer2) was also
performed with similar results (data not shown). To test
for possible dominant activity of a Merlin truncation, we
examined the nonmutant class flies from these same ex-
periments for phenotypes similar to those expressed by
Merlin  mutants.
In the control experiments, we observed almost com-
plete genetic rescue with the mycMer1 transgene (Fig. 2
A). Surprisingly, even stronger genetic rescue was ob-
served with a truncated Merlin protein missing the
COOH-terminal 35 amino acid residues (mycMer1–600).
This improved genetic rescue over mycMer1 was consis-
tently observed with independent transgenic lines, suggest-
ing that the truncated form has increased in vivo function.
We also observed partial rescue of Mer4 lethality with two
even shorter NH2-terminal Merlin transgenes, mycMer1–350
and mycMer1–375 (Fig. 2 A). All of the rescued flies were
phenotypically wild-type and did not possess any of the
characteristic Mer3 phenotypes. Expression of mycMerDBB
and mycMerBBA failed to rescue Mer4 lethality (Fig. 2 A),
indicating that this region has essential functions. In con-
trast, expression of mycMer3 partially rescued Mer4 lethal-
ity. However, unlike rescued flies from other experiments,
all of the mycMer3 rescued flies expressed wing pheno-
types similar to those expressed by flies carrying the origi-
nal Mer3 allele. No rescue was observed with expression of
any other Merlin truncation. Taken together, the results
indicate that all essential Merlin functions reside in the
NH2-terminal 350 amino acids of the protein.
In the same genetic experiments, nonmutant class sib-
lings that carried ubiquitously expressing Mer transgenes
were examined for dominant phenotypes. None of the
NH2- or COOH-terminal deletions displayed any domi-
nant phenotype in a Mer1 background. In contrast, we ob-
served dominant phenotypes resulting from expression of
the Merlin BB mutant proteins. This dominant phenotype
included a broadening of the wing blade, variably pene-
trant ectopic wing vein material (primarily around the sec-
Figure 4. Blue Box mutations
are retained at the plasma
membrane. Subcellular local-
ization of Merlin Blue Box
mutant proteins in S2 cells and
wing imaginal epithelium:
GFPMer1 ( A–C), mycMer1
(D), GFPMer3 ( E–G),
mycMer3 (H), GFPMerDBB (I–
K), and mycMerDBB ( L ). All
GFP Merlin fusion proteins
were visualized using the in-
herent fluorescence of the
GFP moiety; Mer3 and MerDBB
were visualized in the imaginal
disc epithelium using guinea
pig anti-Merlin and a CY3-
conjugated secondary anti-
body. For experiments in S2
cells, samples were collected
from three time points: 1 h
AHS (A, E, and I), 3 h AHS
(B, F, and J), and 6 h AHS (C,
G, and K). The subcellular lo-
calization of the Merlin BB
mutant proteins was examined
in larval wing imaginal epithe-
lia (D, H, and L). GFPMer1 has a wild-type Merlin distribution in S2 cells and in tissue (A–D). Upon induction, GFPMer3 is targeted to
the plasma membrane of S2 cells (E). Unlike GFPMer1, much of the GFPMer3 protein remains at the plasma membrane at later time
points: 3 h AHS (F) and 6 h AHS (G). In tissue, mycMer3 displays both punctate and cytoplasmic localization with no discernible differ-
ence from wild type (H). MerDBB is exclusively associated with the plasma membrane in both S2 cells (I–K) and imaginal disc tissue (L).
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ond wing vein), anterior and posterior cross vein defects,
and ectopic bristles or sense organs (Fig. 5, C and D and
data not shown). The most striking quality of this domi-
nant phenotype was the enlargement of the wing blade, re-
sulting in a curvature of the wing surface. Furthermore,
high levels of expression of the Merlin BB mutant pro-
teins in the wing blade under two different Gal4 drivers
(engrailedciBeGal4, apterousmd5 Gal4) resulted in an out-
held wing phenotype associated with alterations in the
wing hinge morphology (data not shown).
The broadening of the wing blade we observed with ex-
pression of Merlin BB mutations is characteristic of muta-
tions that cause increased cell proliferation in the wing
(Mahoney et al., 1991; Boedigheimer and Laughon, 1993;
Bryant et al., 1993). To examine this phenotype in more
detail, we compared the surface area of wings expressing
Merlin BB proteins or wild-type Merlin under the en-
grailed GAL4 driver. As expected of an overproliferation
phenotype, we observed a significant increase in the total
surface area of wings expressing BB mutant proteins (Fig.
5 E). The area of overgrowth was localized to the posterior
half of the wing where the engrailed Gal4 specifically
drives expression (Fig. 5 B, shaded area), although a de-
crease in surface area was observed between wing veins 2
and 3, a region anterior to the expression of the transgene.
To determine whether the increase in area we observed
was due to increased cell number or increased cell size, we
measured the densities of wing hairs at several positions
within the wing blade. (Each wing blade cell secretes a sin-
gle hair.) The overall wing hair density in wings expressing
BB Merlin proteins was indistinguishable from that in wings
expressing a wild-type protein (data not shown), indicating
that the broadening of the wing results from an increase in
cell number rather than in cell size. As shown in the somatic
mosaic analysis, loss of Mer function resulted in overprolif-
eration of mutant cells. Similarly, ectopic expression of BB
mutant proteins resulted in increased proliferation. These
results suggest that the BB mutant proteins act in a domi-
nant-negative manner and therefore interfere with the ac-
tivity of wild-type protein.
To confirm that the BB mutations have dominant-nega-
tive activity, we examined the modification of the domi-
nant MerDBB wing phenotype in response to alteration of
endogenous gene dose. As would be expected for an anti-
morphic allele, dominant MerDBB wing phenotypes were
enhanced by a reduction of endogenous gene dose (Mer4/1)
and were suppressed in response to an increase in the level
of endogenous Merlin (1/1;P{cos Mer1}; Table I). These
results confirm that Merlin BB proteins act as dominant-
negative proteins.
Based on the in vivo activity assay, mycMer1–600 appears
to behave as an activated protein. An additional way to
test this proposal is to determine whether mycMer1–600 is
able to rescue the dominant-negative activity of the BB
mutant proteins. We examined the BB phenotype of wings
coexpressing MerDBB and either wild-type Merlin (mycMer1)
or the putative activated form (mycMer1–600). Flies ex-
pressing mycMerDBB under the apterous Gal4 driver dis-
play wings held at an average angle of 458 from the body
axis (Fig. 6 A). This phenotype appears to be caused by in-
creased proliferation in the wing hinge region (data not
shown). Coexpression of mycMer1 with mycMerDBB re-
sulted in a slight suppression in the degree of outheld
wings (Fig. 6 B). However, when mycMer1–600 was coex-
pressed with the mycMerDBB, we observed a dramatic sup-
pression of the dominant BB wing phenotype (Fig. 6 C). In
a control experiment, the COOH-terminal half of Merlin
Figure 5. Expression of MerDBB results in an increase in the size
of the wing blade. (A) Expression of UASMer1 under the en-
grailed GAL4 driver. (C) Expression of two copies of UASMerDBB
under the engrailed GAL4 driver results in the expansion of the
wing blade. Camera lucida drawings of mounted wings expressing
UASMer1 (B) and UASMerDBB (D) under the engrailed GAL4
driver were made to compare the overall wing area (E) and to de-
termine and compare the surface area of individual regions of the
wing blade. The shaded area in B delineates the approximate do-
main of expression under this driver. Values shown in D repre-
sent the percent change in area in these regions of the wing blade
when compared with wings expressing Mer1. The overgrowth
phenotype observed in wings expressing UASMerDBB is limited to
the region of the wing where the construct is expressed (D). Loss
of area in regions of the wing blade where the construct is not ex-
pressed may be due to a compensation mechanism. The drawing
in D also displays several of the venation defects associated with
expression of MerDBB. (E) The overall wing area is increased in
wings expressing Merlin Blue Box mutant proteins. The severity
of this effect is dependent on the severity and the dose of the mu-
tation. When the t test was applied to these values the difference
in wing area between wings expressing wild-type Merlin and
those expressing Merlin Blue Box mutants was found to be signif-
icant (P , 0.001).
Table I. Genetic Characterization of MerlinDBB
Genotype* n
Ectopic wing
material‡
Defects in
cross veins§
1/1; 1/1 100 0 0/0
1/1; Mer1/1 100 0 0/0
1/1; MerDBB/1 350 53 4/1
Mer4/1; MerDBB/1 74 78 12/4
1/1; MerDBB/1;P[cosMer1]/1 74 28 1/0
*UASMerlin transgenes driven under apterous Gal4 driver.
‡Percent of flies observed with these phenotypes.
§Anterior cross vein/posterior cross vein disruptions.The Journal of Cell Biology, Volume 141, 1998 1596
was coexpressed with mycMerDBB, and no suppression of
the phenotype was observed (Fig. 6 D). The ability of
mycMer1–600 to suppress the dominant BB phenotype sup-
ports the idea that this is an activated form of the Merlin
protein.
Competition Experiments
To directly observe the dominant-negative behavior of
mycMerDBB, we examined the localization of wild-type
Merlin protein in the presence of mycMerDBB. We cotrans-
fected  Drosophila S2 cells with GFPMer1 and either
mycMer1 or mycMerDBB and examined the localization of
both proteins. In S2 cells cotransfected with either the
mycMer1 or mycMer1–600 competitor proteins, the major-
ity of GFPMer1 in these cells was associated with charac-
teristic punctate cytoplasmic structures 5 h after induction
(Fig. 7, A and D) as was shown earlier (Figs. 3 C and 4 C).
However, in almost all S2 cells cotransfected with myc-
MerDBB competitor, wild-type GFPMerlin remained at the
plasma membrane (Fig. 7, B–D). This result suggests that
localization to the plasma membrane is not sufficient for
Merlin activity and that mycMerDBB interferes with wild-
type Merlin function by causing it to accumulate at the
plasma membrane in a nonfunctional state.
Discussion
Although the protein 4.1 family has typically been charac-
terized as a group of membrane–skeletal proteins, recent
studies have revealed a diversity of function, some of
which may not be primarily related to the canonical mem-
brane–cytoskeletal linker function (for review see Mc-
Cartney and Fehon, 1997). In addition, recent genetic
studies in particular have implicated protein 4.1 family
proteins in mediating the intercellular interactions that
regulate cell proliferation. For example, mutations in
Drosophila  expanded, a divergent member of the protein
4.1 superfamily that localizes to the adherens junction, re-
sult in overproliferation of the cells that form the adult
wings (Boedigheimer and Laughon, 1993). Previous ex-
periments have shown that proliferation in this tissue is
controlled by cell–cell interactions, mediated by at least
three known signal transduction pathways, wingless, deca-
pentapelegic, and Epidermal Growth Factor (Edgar and
Lehner, 1996). Studies of Drosophila Coracle, a protein
4.1 homologue, indicate that it is associated with the sep-
tate junction, a structure that has previously been impli-
cated in the regulation of cell growth (Woods and Bryant,
1993), and that coracle mutations interact genetically with
a hypermorphic mutation of the Drosophila Epidermal
Growth Factor-receptor homologue (Fehon et al., 1994). In
addition, the human NF2 tumor-suppressor gene Merlin
clearly has a role in maintaining proper regulation of cell
proliferation.
Figure 6. Constitutively activated COOH-terminal truncation of
Merlin suppresses the dominant MerDBB phenotype. Flies coex-
pressing either wild-type or truncated forms of Merlin under the
apterousmd52 GAL4 (apGal4) enhancer trap were examined for
suppression of the MerDBB outheld wing phenotype. Flies were
placed into one of five classes of wings, each corresponds to the
degree of which the wings were outheld from the central body
axis: 08, 22.58, 458, 67.58, and 908. The y-axis shows the percent of
flies within a class. When outcrossed, flies with the apGal4 UAS-
MerDBB genotype hold their wings out at an average angle of 458
(A). Flies expressing both UASMer1 and UASMerDBB show only
a slight difference from the control (B). However, expression of
UASMer1–600 greatly suppresses the outheld wing phenotype (C);
with two independent insertion lines of mycMer1–600, we observed
almost complete suppression. As a negative control, the expres-
sion of the nonrescuing UASMer351–635 has a profile similar to the
outcrossed stock (D).
Figure 7. MerDBB alters subcellular distribution of wild-type Mer-
lin in S2 cells. The localization of GFPMer1 was examined in S2
cells cotransfected with either mycMer1 or mycMerDBB 5 h AHS.
Cells were stained with an anti-myc antibody to confirm expres-
sion of the second protein (data not shown). In S2 cells cotrans-
fected with a mycMer1 (A) or mycMer1–600 (data not shown), all
of the GFPMer1 protein localizes to cytoplasmic structures 5 h
AHS. However, in S2 cells cotransfected with mycMerDBB, a con-
siderable fraction of the GFPMer1 accumulates at the plasma
membrane (B and C). In D, the data from this experiment are
summarized. Three classes of GFPMer1 localization were ob-
served 5 h AHS. Bar, 5 mm.LaJeunesse et al. Functional Analysis of Drosophila NF2/Merlin Homologue 1597
In NF2, as well as in other diseases involving tumor-sup-
pressor genes, a genetically heterozygous individual expe-
riences somatic loss of the second copy of the gene in
certain tissues (called loss of heterozygosity or LOH), re-
sulting in the formation of tumors in those tissues. These
individuals are then genotypically mosaic with respect to
the tumor-suppressor gene. Although NF2 was originally
characterized as a disease of the central nervous system
(CNS), somatic loss of NF2 is believed to occur in the
Schwann cells that form the myelin sheath surrounding
CNS axons. The glial cells form a polarized epithelium
that isolates the axons from the surrounding environment.
Thus, although Merlin is expressed in the Drosophila CNS
(McCartney and Fehon, 1996), we have concentrated our
analysis of Drosophila Merlin function in epithelial tissues,
which also express Merlin and are readily amenable to ex-
perimental analysis.
We simulated loss of heterozygosity in Drosophila using
somatic mosaic analysis in which the effects of homozy-
gous loss of gene function in a patch of cells (a clone) were
examined in an otherwise heterozygous background. Us-
ing this system, we demonstrated that loss of Merlin func-
tion during larval development results in a two- to three-
fold increase in proliferation relative to the wild-type
sister clone. This hypertrophied tissue is morphologically
normal, indicating that loss of Merlin function specifically
affects proliferation rather than differentiation or mor-
phogenesis. This conclusion is supported by the prolifera-
tion defect we observed in tissues overexpressing Merlin
Blue Box mutant proteins. Interestingly, as with human
NF2, the overproliferation we observed seems moderate
and does not result in the extreme hyperplasia observed in
other  Drosophila  “tumor suppressors” (Mahoney et al.,
1991; Bryant et al., 1993; Xu et al., 1995) or in the malig-
nant transformation associated with many human cancers.
As we demonstrated in this study, the degree of overpro-
liferation observed was dependent on the mutant allele of
Merlin examined. Similarly, individuals with NF2 display a
range of tumor growth rates that may reflect differences in
their Merlin genotypes. In general, nonsense mutations in
human NF2 result in more severe phenotypes than mis-
sense mutations. Alternatively, it is possible that some of
the observed differences in the severity of NF2 is due to
second site modifying loci. Currently, we are using the ge-
netic techniques available in the Drosophila system to
identify second site modifiers of Merlin mutant pheno-
types.
To understand how Merlin functions in the cell and how
these functions relate to the regulation of proliferation, we
identified important functional domains within Merlin re-
quired for its activity and proper subcellular localization.
Genetic rescue experiments using a series of NH2- and
COOH-terminal truncations of Merlin indicate that all es-
sential Merlin functions reside in the CNTR. This result,
though somewhat surprising, is consistent with recent re-
sults from other protein 4.1 superfamily members. Studies
of Drosophila Coracle, a protein 4.1 homologue, indicate
that the CNTR of this protein performs several essential
functions within the septate junction (Ward et al., 1998).
In addition, recent studies of the ERM proteins indicate
that sequences COOH-terminal to the CNTR may play a
primarily regulatory role, a model that also seems to apply
to Merlin (see below). While there are clearly family mem-
bers that have a more complex functional organization,
taken together these results indicate that the CNTR of
many protein 4.1 superfamily members acts as an indepen-
dent functional domain. The diversity of identified protein
4.1 superfamily members suggests that during the course
of evolution, the essential function of this domain, proba-
bly to serve as a targeting sequence to a particular region
of the cell membrane, has been adapted repeatedly to dif-
ferent proteins (Fehon et al., 1997).
In humans, many of the mutations associated with NF2
are predicted to generate truncated forms of Merlin as a
result of nonsense mutations (Jacoby et al., 1996; Welling
et al., 1996). Given the results presented here, some of
these truncated products should retain partial function,
just as the mycMer1–350 allele appears to be partially func-
tional. Although it is possible that this apparent discrep-
ancy results from differences in human and Drosophila
Merlin function, expression of human NF2 is sufficient for
genetic rescue of lethal Drosophila Merlin alleles, indicat-
ing that their functions are conserved (McCartney, B., V.
Ramesh, and R. Fehon, unpublished observations). Un-
like other protein 4.1 family members (Algrain et al., 1993;
Ward et al., 1998), the CNTR of Merlin is poorly targeted
to the plasma membrane, thereby decreasing functional
protein levels. Thus, even when overexpressed, the CNTR
provides only partial genetic rescue. It is therefore not sur-
prising that human NF2 alleles that truncate COOH-ter-
minally to the CNTR produce severe phenotypes even
though the proteins they encode may retain all essential
Merlin functions. Further tests need to be performed to
confirm this hypothesis. If correct, stabilization of mutant
NF2 products containing an intact CNTR (but lacking
COOH-terminal targeting sequences) could be an effec-
tive therapeutic strategy for some patients afflicted with
NF2 because it would increase the levels of a partially
functional Merlin protein.
We have shown that mycMer1–600 acts as an activated
protein that displays greater rescuing activity and sup-
presses the phenotypes produced by a dominant-negative
form of Merlin. Pulsed expression of Mer1–600 in S2 cul-
tured cells under an inducible promoter indicates that the
levels of expression and the stability of this protein are not
significantly different from wild-type Merlin (data not
shown). Thus, the simplest explanation for this phenome-
non is that the COOH-terminal region contains a domain
important for reducing the activity of Merlin. Recent stud-
ies demonstrate that ERM protein activity is regulated by
a Rho-based signaling pathway (Takaishi et al., 1995;
Hirao et al., 1996; Mackay et al., 1997). Rho-Kinase has
been shown to phosphorylate a conserved threonine
within the COOH-terminal 35 amino acids of all ERM
proteins and thereby regulate the conformational change
that occurs during a putative transition from an inactive to
an active state (Matsui et al., 1998). Although the COOH-
terminal 35 amino acids of Merlin are divergent from
those of the ERM proteins, the threonine residue phos-
phorylated by Rho-Kinase is conserved (McCartney and
Fehon, 1996), suggesting that Merlin could use a similar
mechanism for switching between an inactive and an ac-
tive state. Creation of an activated Merlin protein by the
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sistent with this notion, but further studies are required to
confirm this regulatory role. It is interesting to note in this
regard that an isoform of human and mouse NF2 that al-
ters the COOH terminus of Merlin has been identified
(isoform II; Haase et al., 1994; Pykett et al., 1994). Recent
studies indicate that isoform II, which retains the con-
served threonine residue, is less functional than isoform I
in suppressing growth (Sherman et al., 1997), consistent
with the idea that the COOH terminus of Merlin has regu-
latory functions.
Two Merlin mutations described here, the dominant-
negative MerDBB and the activated Mer1–600, are found pri-
marily at the plasma membrane. This apparently con-
tradictory result, that two mutant forms of Merlin with
opposite functions both localize to the plasma membrane,
indicates that localization to the plasma membrane is not
sufficient for Merlin function. We propose that Merlin
normally undergoes an activation process that occurs at
the cytoplasmic face of the plasma membrane (Fig. 8). In
our model, not only is MerDBB refractory to activation, but
it also inhibits activation of endogenous wild-type Merlin,
thus causing wild-type Merlin to accumulate at the plasma
membrane in a nonfunctional state and producing a domi-
nant phenotype. In contrast, Mer1–600 exists in a constitu-
tively activated state, thereby evading the block presented
by MerDBB and suppressing the dominant BB mutant phe-
notype. The two functional states of wild-type Merlin may
represent two distinct conformations of the protein, as has
been shown for ERM proteins (Berryman et al., 1995;
Bretscher et al., 1995). Alternatively, Merlin may associate
with two distinct binding partners at the membrane. In ei-
ther case, one state may serve to associate Merlin with the
membrane, and the second may be required for Merlin ac-
tivation.
In this report, we have shown that Merlin is required for
the regulation of proliferation in Drosophila epithelial
cells and that it functions at the plasma membrane. The
mechanism by which Merlin functions to regulate cellular
proliferation is still unclear. Recent evidence suggests that
other proteins of the protein 4.1 superfamily operate by
organizing functional regions within the plasma mem-
brane (Helander et al., 1996; Ward et al., 1998). Merlin
may function in a similar fashion by coordinating interac-
tions of transmembrane signaling molecules and cytoplas-
mic factors that regulate cellular proliferation. We now
plan to elucidate the signaling pathways that Merlin regu-
lates as well as identify genes involved in its regulation.
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